HomeNewsBusinessMarketsMSCI May rejig could attract $2 billion inflows; Indus Towers, PB Fintech, Mankind Pharma likely inclusions

MSCI May rejig could attract $2 billion inflows; Indus Towers, PB Fintech, Mankind Pharma likely inclusions

India's weight in the MSCI Emerging Market Index stands closer to 18 percent, marking a significant leap from just around 8 percent in early 2020. Nuvama Alternative expects it to rise further and hit the 20 percent mark in the second half of 2024.

May 14, 2024 / 10:26 IST
Story continues below Advertisement
Adjustments to the MSCI indices will come into effect from May 31.
Adjustments to the MSCI indices will come into effect from May 31.

The May review of the MSCI indices is slated to take place on May 15, with the adjustments coming into force on May 31. Based on calculations done by Nuvama Alternative & Quantitative Research, the inclusions to the MSCI indices could usher inflows worth $2 billion for domestic equities.

Stocks like Indus Towers, PB Fintech, Phoenix Mills, Sundaram Finance, Mankind Pharma and others are the key contenders to get a pass into the MSCI Standard index. In contrast, Nuvama sees Paytm, Indraprastha Gas, and Berger Paints as the possible exclusions.

Story continues below Advertisement

The contenders

Some stocks that emerge as high conviction contenders to be included in the MSCI Global Standard index include Indus Towers, PB Fintech, Phoenix Mills, Sundaram Finance, Solar Industries India, NHPC, Bosch, Jindal Stainless, Torrent Power, Mankind Pharma, JSW Energy, and Canara Bank.